Journal profile · Allergy
Journal of Allergy and Clinical Immunology
ISSN 0091-6749 · eISSN 1097-6825 · Mosby Inc. · UNITED STATES · Monthly · Founded 1971
Journal of Allergy and Clinical Immunology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 11.29; hybrid open access; APC about USD 4,900; median 115 days to acceptance (113 articles, last 24 months); community-reported acceptance: about 5%; 1,570 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Allergy and Clinical Immunology is published by Mosby Inc. and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Allergic Rhinitis and Sensitization and Food Allergy and Anaphylaxis Research, together about 45.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the American Academy of Allergy, Asthma and ImmunologyThe Journal of Allergy and Clinical Immunology publishes high-impact, cutting-edge basic, clinical and translational research papers in Allergy, Asthma and Immunology. Articles cover such topics as asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases, and include clinical trials and mechanistic studies that report on novel therapies, insights into underlying mechanisms, and other discoveries that will inform our understanding of these diseases and ultimately improve the diagnosis and management of patients. Authors are also welcome to submit to the journal's companion titles, The Journal of Allergy and Clinical Immunology: In Practice and the Gold Open Access title, The Journal of Allergy and Clinical Immunology: Global. For more information on the articles reviewed by JACI: In Practice and JACI: Global, please visit their respective websites which are linked here: www.jaci-inpractice.org www.jaci-global.org
From the journal's Aims & Scope
Research area (LetPub): Allergy
Editor-in-chief Zuhair K. BallasPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 95, United Kingdom 8, Germany 8, Japan 5, Italy 4 (147 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine19.7%
- Allergic Rhinitis and SensitizationMedicine14.9%
- Food Allergy and Anaphylaxis ResearchMedicine10.6%
- Dermatology and Skin DiseasesMedicine4.8%
- Contact Dermatitis and AllergiesMedicine4.6%
- Respiratory and Cough-Related ResearchMedicine3.7%
- Drug-Induced Adverse ReactionsMedicine3.6%
- Mast cells and histamineImmunology and Microbiology3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Allergy | Zone 1 |
| Minor | Immunology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Allergy | Zone 1 |
| Minor | Immunology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Allergy | Zone 1 |
| Minor | Immunology | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 11.29LetPub ·
- Impact factor (publisher)
- 11.7Publisher website ·
- CiteScore 2026-06
- 19.2LetPub ·
- CiteScore (publisher)
- 19.2Publisher website ·
- SJR 2026-06
- 3.81LetPub ·
- SNIP 2026-06
- 2.79LetPub ·
- h-index
- 262LetPub ·
- h-index
- 413OpenAlex ·
- i10-index
- 16,491OpenAlex ·
- 2-year mean citedness
- 2.07OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 30.79%LetPub ·
Volume
- Articles per year
- 308LetPub ·
Articles by year OpenAlex count · 56,982 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,348 | 427 | 201 |
| 2025 | 1,570 | 853 | 2,495 |
| 2024 | 1,373 | 498 | 6,193 |
| 2023 | 1,295 | 795 | 9,738 |
| 2022 | 1,226 | 406 | 13,921 |
| 2021 | 1,197 | 732 | 21,208 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
115 daysMedian, submission to acceptance · P25–P75 69 days – 157 days
- Acceptance to online
- median 19 days (112 articles)
- Submission to online
- median 138 days
- Sample
- 113 articles with submission and acceptance dates (846 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 5%LetPub ·
- Acceptance rate (publisher)
- 20%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 41 daysPublisher website ·
- Submission to acceptance
- 116 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,900 / EUR 4,580 / GBP 3,920 / JPY 607,750 | — | — | |
| Publisher website | USD 5,200 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Graphical abstract
- Optional
Article types accepted3, with length limits
- correspondenceCorrespondence may be submitted in a standalone format or in regard to a published JACI article. Correspondence related to papers published in JACI must be rece…main text ≤ 1,000 words · figures and tables ≤ 2 · references ≤ 10
- original articler publication only as a Correspondence. Original Articles should not exceed 3500 words, not including the abstract, figure legends, and referencesmain text ≤ 3,500 words · abstract ≤ 250 words · figures and tables ≤ 5
- review articleReview articles published in the Journal are invited by the Editors. Proposals for review articles may be emailed to the Editorial Office ([email protected]), b…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Preprints, Trial registration / reporting guidelines
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest
All authors must disclose all financial relationships for themselves and their immediate family/significant others. The Journal requires all authors to acknowledge, on the title page of the manuscript, all funding sources that supported their work and any commercial associations that might pose a conflict of interest. These include consultant arrangements, speakers' bureau participation, stock or …
Source ↗Publisher website ·- Data availability Data access
Nucleotide Sequence Data. When manuscripts include or describe original sequence data, authors must submit these data to GenBank prior to publication of their article. A footnote must include the accession number under which the data were submitted. Instructions are available from http://www.ncbi.nlm.nih.gov/Genbank or http://www.ebi.ac.uk/embl/SubmissionProtein Sequence Data. When manuscripts inc…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Preprints Preprint manuscripts
We allow submissions that have been posted on preprint servers. Upon publication in our journal, authors are requested to update their preprint article with a link to the final published version. Elsevier’s preprint policy is available at: https://www.elsevier.com/about/policies/sharing.Data accessNucleotide Sequence Data. When manuscripts include or describe original sequence data, authors must s…
Source ↗Publisher website ·- Trial registration / reporting guidelines PRISMA guidelines for systematic reviews and meta-analyses
For meta-analysis of RCTs, we encourage authors to consult the recommendations of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement, available at www.prisma-statement.org.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Mosby Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1971
- ISSN
- 0091-6749
- Electronic ISSN
- 1097-6825
- Society / sponsor
- American Academy of Allergy
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Allergy and Clinical Immunology
What CAS zone is Journal of Allergy and Clinical Immunology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Allergy and Clinical Immunology is in Zone 1 of Medicine, and in Zone 1 of the minor category Allergy / Immunology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Allergy and Clinical Immunology?
The latest impact factor listed by LetPub is 11.29; CiteScore 19.2, h-index 413.
How long does peer review take at Journal of Allergy and Clinical Immunology?
Based on the dates recorded on 113 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 115 days (interquartile range 69–157 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 5%”; the journal's website gives an acceptance rate of 20%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Allergy and Clinical Immunology?
According to the journal's author guidelines: Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Allergy and Clinical Immunology based?
Of the 147 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (95), United Kingdom (8) and Germany (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Allergy and Clinical Immunology?
According to LetPub and DOAJ records, Journal of Allergy and Clinical Immunology is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Journal of Allergy and Clinical Immunology open access, and what is the APC?
Journal of Allergy and Clinical Immunology is a hybrid journal. For open-access publication: APC about USD 4,900.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .